Monmouth Junction, NJ, United States of America

Richard J Budhu


Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 78(Granted Patents)


Location History:

  • Monmouth Junction, NJ (US) (1994 - 2000)
  • Dayton, NJ (US) (2007)

Company Filing History:


Years Active: 1994-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Richard J Budhu: Innovator in Pharmaceutical Compounds

Introduction

Richard J Budhu is a notable inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on compounds that have therapeutic applications in treating immune-mediated diseases.

Latest Patents

One of his latest patents is titled "Aminoalkylphosphonates and related compounds as Edg receptor agonists." This invention encompasses compounds or Formula (I), along with their pharmaceutically acceptable salts and hydrates. These compounds are particularly useful for treating immune-mediated diseases and conditions, such as bone marrow, organ, and tissue transplant rejection. Additionally, he has developed a patent for "Pyrrolidine and piperidine modulators of chemokine receptor activity." This invention is directed towards pyrrolidine and piperidine compounds that serve as modulators of chemokine receptor activity, specifically targeting various chemokine receptors.

Career Highlights

Throughout his career, Richard has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Merck & Co., Inc. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Richard has collaborated with notable professionals in his field, including Sander G Mills and Jeffrey John Hale. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Richard J Budhu is a distinguished inventor whose work in pharmaceutical compounds has the potential to greatly benefit patients with immune-mediated diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…